Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 12890841

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2003 Jul 31
First author
Yang JC

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2003 Jul 31;349(5):419-21. doi: 10.1056/NEJMp030061.
    note
    Source null
    related pmid
    12890838
    relationship
    Comment in
  2. citation
    N Engl J Med. 2003 Oct 23;349(17):1674. doi: 10.1056/NEJM200310233491719.
    note
    Source null
    related pmid
    14573745
    relationship
    Comment in
  3. citation
    Curr Oncol Rep. 2004 Mar;6(2):85-6. doi: 10.1007/s11912-004-0017-2.
    note
    Source null
    related pmid
    14751083
    relationship
    Comment in

Authors and identifiers

  1. name
    Yang JC
    type
    Author
  2. name
    Haworth L
    type
    Author
  3. name
    Sherry RM
    type
    Author
  4. name
    Hwu P
    type
    Author
  5. name
    Schwartzentruber DJ
    type
    Author
  6. name
    Topalian SL
    type
    Author
  7. name
    Steinberg SM
    type
    Author
  8. name
    Chen HX
    type
    Author
  9. name
    Rosenberg SA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Yang JC
    type
    Author
  2. name
    Haworth L
    type
    Author
  3. name
    Sherry RM
    type
    Author
  4. name
    Hwu P
    type
    Author
  5. name
    Schwartzentruber DJ
    type
    Author
  6. name
    Topalian SL
    type
    Author
  7. name
    Steinberg SM
    type
    Author
  8. name
    Chen HX
    type
    Author
  9. name
    Rosenberg SA
    type
    Author
bibliography ids
  1. nci-bib-4bc1ad3e01499dbfc63fa844
book metadata
content sha256
098cde1659b0eea93ede12235e3ddb510d53a531d6eb6a84d912eba29287f62c
document type
citation
dois
  1. 10.1056/NEJMoa021491
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:12890841
immutable id
pubmed:12890841@098cde1659b0eea93ede12235e3ddb510d53a531d6eb6a84d912eba29287f62c
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
5
name
The New England journal of medicine
nlm unique id
0255562
pages
427-34
volume
349
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2003 Jul 31;349(5):419-21. doi: 10.1056/NEJMp030061.
    note
    Source null
    related pmid
    12890838
    relationship
    Comment in
  2. citation
    N Engl J Med. 2003 Oct 23;349(17):1674. doi: 10.1056/NEJM200310233491719.
    note
    Source null
    related pmid
    14573745
    relationship
    Comment in
  3. citation
    Curr Oncol Rep. 2004 Mar;6(2):85-6. doi: 10.1007/s11912-004-0017-2.
    note
    Source null
    related pmid
    14751083
    relationship
    Comment in
outcomes validated
false
pmid
12890841
provenance
batch id
2d0158fe73b50bb1a4bf
provider
NCBI PubMed ESummary
record sha256
8bb6843fa9421ebeb3200c6f61d69659c3324971edf866a7257bc47e24531a98
response sha256
d46de44782d91ef4394e88a69f82b1ee22148e8c4cf1534eb36c80479345e70e
retrieved at
2026-09-09T23:45:50.935339+00:00
publication date
display
2003 Jul 31
precision
day
year
2003
publication types
  1. Clinical Trial
  2. Clinical Trial, Phase II
  3. Comparative Study
  4. Journal Article
  5. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/12890841/
title
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.

Preserved source evidence · Not medical advice